TMDX Dividend: Transmedics Group Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

TMDX Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	566	441	241	93	30	25
Revenue Growth (YoY)	41%	83%	159%	210%	20%	9%
Cost of Revenue	225	179	88	28	9	9
Gross Profit	341	262	154	65	21	16
Selling, General & Admin	181	168	117	69	38	24
Research & Development	64	55	36	26	22	18
Operating Expenses	246	225	153	96	60	43
Other Non Operating Income (Expenses)	--	--	--	--	--	0
Pretax Income	92	36	-27	-36	-44	-28
Income Tax Expense	1	0	-1	0	0	0
Net Income	91	35	-25	-36	-44	-28
Net Income Growth	184%	-240%	-31%	-18%	56.99%	-15%
Shares Outstanding (Diluted)	41	35	33	29.56	27.62	24.7
Shares Change (YoY)	14%	6%	12%	7%	12%	74%
EPS (Diluted)	2.24	1.01	-0.77	-1.23	-1.6	-1.16
EPS Growth	149%	-231%	-37%	-23%	38%	-51%
Free Cash Flow	120	-81	-165	-57	-32	-30
Free Cash Flow Per Share	2.92	-2.31	-5	-1.92	-1.15	-1.21
Gross Margin	60.24%	59.41%	63.9%	69.89%	70%	64%
Operating Margin	16.78%	8.39%	0%	-33.33%	-130%	-104%
Profit Margin	16.07%	7.93%	-10.37%	-38.7%	-146.66%	-112%
Free Cash Flow Margin	21.2%	-18.36%	-68.46%	-61.29%	-106.66%	-120%
EBITDA	95	37	0	-28	-38	-25
EBITDA Margin	16.78%	8.39%	0%	-30.1%	-126.66%	-100%
D&A For EBITDA	0	0	0	3	1	1
EBIT	95	37	0	-31	-39	-26
EBIT Margin	16.78%	8.39%	0%	-33.33%	-130%	-104%
Effective Tax Rate	1.08%	0%	3.7%	0%	0%	0%